secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Therapeutics, Inc. (ODTX)
CIK:        0001882782
Form:       8-K
Filed at:   2026-06-23T12:45:40+00:00
Accession:  0001193125-26-278581
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Therapeutics posts June 2026 corporate presentation on website
----------------------------------------------------------------------

- Presentation furnished as Exhibit 99.1; no specific financial or clinical updates provided in filing text.
- No detailed content available; summary based solely on filing metadata.
- Ticker ODTX; presentation posted on investors.odysseytx.com.
- Event reported under Regulation FD; no earnings or material agreements disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1882782/000119312526278581/0001193125-26-278581-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1882782/000119312526278581/odtx-20260623.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-278581

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer